• Six patients who developed urticaria, dyspnea, and anaphylactic shock due to topical application of chlorhexidine gluconate solution are described. Chlorhexidine gluconate was confirmed as the causative agent of type I hypersensitivity by intradermal, scratch, and epicutaneous tests. To prevent life-threatening adverse reactions, it seems important to use chlorhexidine gluconate on wound surfaces at a concentration of 0.05%, as recommended by the manufacturer; chlorhexidine gluconate may not be suitable for application to mucous membranes.
(Arch Dermatol 1989;125:50-52)
Okano M, Nomura M, Hata S, et al. Anaphylactic Symptoms due to Chlorhexidine Gluconate. Arch Dermatol. 1989;125(1):50–52. doi:10.1001/archderm.1989.01670130052005
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: